Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24166282

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Breast Cancer Res Treat
Publication date
2013 Nov
First author
Smith JW 2nd

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Smith JW 2nd
      type
      Author
    2. name
      Vukelja S
      type
      Author
    3. name
      Rabe A
      type
      Author
    4. name
      Wentworth-Hartung N
      type
      Author
    5. name
      Koutrelakos N
      type
      Author
    6. name
      Shao SH
      type
      Author
    7. name
      Whittaker T
      type
      Author
    8. name
      Wang Y
      type
      Author
    9. name
      Asmar L
      type
      Author
    10. name
      McDowell DO
      type
      Author
    11. name
      Mukhopadhyay P
      type
      Author
    12. name
      O'Shaughnessy J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Smith JW 2nd
      type
      Author
    2. name
      Vukelja S
      type
      Author
    3. name
      Rabe A
      type
      Author
    4. name
      Wentworth-Hartung N
      type
      Author
    5. name
      Koutrelakos N
      type
      Author
    6. name
      Shao SH
      type
      Author
    7. name
      Whittaker T
      type
      Author
    8. name
      Wang Y
      type
      Author
    9. name
      Asmar L
      type
      Author
    10. name
      McDowell DO
      type
      Author
    11. name
      Mukhopadhyay P
      type
      Author
    12. name
      O'Shaughnessy J
      type
      Author
    bibliography ids
    1. nci-bib-e56e53bfafc9cb7a5fc71b4b
    book metadata
    content sha256
    1119d3835f8ed5f3be547ddef2094edd33be50f8c6a69237edcce475b0038d49
    document type
    citation
    dois
    1. 10.1007/s10549-013-2742-4
    electronic publication date
    display
    2013 Oct 29
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24166282
    immutable id
    pubmed:24166282@1119d3835f8ed5f3be547ddef2094edd33be50f8c6a69237edcce475b0038d49
    journal
    abbreviation
    Breast Cancer Res Treat
    issn electronic
    1573-7217
    issn print
    0167-6806
    issue
    2
    name
    Breast cancer research and treatment
    nlm unique id
    8111104
    pages
    381-8
    volume
    142
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24166282
      provenance
      batch id
      af10498814d931b53231
      provider
      NCBI PubMed ESummary
      record sha256
      fe83768c5af8eb5a3c782879c62311bf1a978e2c90672e2089a1d620bdafe740
      response sha256
      077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
      retrieved at
      2026-09-09T23:47:00.193465+00:00
      publication date
      display
      2013 Nov
      precision
      month
      year
      2013
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24166282/
      title
      Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.

      Preserved source evidence · Not medical advice